All In Biotech

Drug Trial Radar · NCT06205641

A Prospective, Multicenter, Randomized Controlled Clinical Study on the Efficacy and Safety of Xuanfei Baidu Granule in the Treatment of Influenza A

Last checked: Nov 20, 2026Latest source record: Jan 16, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingRandomized with 584 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

584

Planned (sponsor's estimate)

Start

Jan 2024

Primary completion

Jun 2024

Study completion Jan 2025

Sponsor

Lead sponsor
Capital Medical UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jan 16, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is a prospective, multicenter, randomized controlled trial and aims to evaluate efficacy and safety of Xuanfei Baidu Granule in the treatment of influenza A. This study plans to enroll 584 subjects. The subjects will be randomly divided into 4 groups according to the ratio of 1:1:1:1, and they will be treated with Xuanfei Baidu Granule Placebo, Xuanfei Baidu Granule, Xuanfei Baidu Granule combined with Baloxavir Marboxil tablet.1 bag of Xuanfei Baidu Granule and Xuanfei Baidu Granule Placebo in the morning and evening, and take with boiling water for 5 days. Baloxavir Marboxil Tablet was taken orally 2 tablets, once a day for 1 day. The subjects were visited every day for 7 days after enrollment.

Conditions

  • Influenza A

Interventions

  • Xuanfei Baidu Granule PlaceboDrug

    Take Xuanfei Baidu Granule Placebo 1 bag in the morning and evening with boiling water for 5 days.

  • Xuanfei Baidu GranuleDrug

    Take Xuanfei Baidu Granule 1 bag in the morning and evening with boiling water for 5 days.

  • Baloxavir Marboxil TabletDrug

    Take Baloxavir Marboxil Tablet 2 tablets orally, once a day, for 1 day.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The time to fever resolution.Time frame: within 7 days of enrollment

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Beijing Chaoyang Hospital

    Beijing, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.